George and Cleary Simpson Award for Emerging Researchers supports early-career scientists studying peripheral nerve transcriptional regulation through omic-level analysis to advance CMT drug development.
Funder: CMT Research Foundation
Due Dates: November 12, 2026 (Optional LOI) | January 29, 2027 (Full application)
Funding Amounts: $75,000 for one year; one recipient per cycle
Summary: Supports early-career scientists pursuing innovative CMT drug development research on transcriptional regulation of the peripheral nerve using omic-level analysis.
Key Information: Proposals outside the cycle’s defined research focus area will not be considered.
The CMT Research Foundation’s George and Cleary Simpson Award for Emerging Researchers supports early-career scientists pursuing high-impact research to overcome barriers to treatments for Charcot-Marie-Tooth disease (CMT). Each cycle focuses on a challenge, topic, or priority selected by the foundation’s research and drug development team. The 2026–2027 focus is transcriptional regulation of the peripheral nerve using omic-level analysis.
Projects may involve basic science, translational, or clinical research applicable to CMT drug development, targeting either an individual CMT subtype or multiple forms. Within the designated focus area, the foundation encourages bold, creative, and innovative approaches. Collaboration across research groups and between academic and industry investigators is highly encouraged. Priority goes to projects with strong scientific merit and high potential to lead to further CMT drug development research.